INS and type 2 diabetes mellitus: Distinct from the Gs-coupled receptors therapeutically targeted to treat insulin deficiency in type 2 diabetes, and in spite of the considerable evidence for the positive role of FFA1 for insulin secretion, the therapeutic potential of FFA1 remains controversial [19, 21, 22, 26, 37].